Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp. Common Stock (NY: NVRO )

3.760 -0.290 (-7.16%)
Streaming Delayed Price Updated: 3:03 PM EST, Dec 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nevro Corp. Common Stock

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
Preview: Nevro's Earnings
Nevro (NYSE:NVRO) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Looking into Nevro's Return on Capital Employed
After pulling data from Benzinga Pro it seems like during Q2, Nevro's (NYSE:NVRO) reported sales totaled $102.33 million. Despite a 29.98% in earnings, the company posted a loss... 
Via Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
On Monday morning, 207 companies hit new 52-week lows. Intriguing Points: The largest company in terms of market cap to set a new 52-week low was Koninklijke Philips (NYSE... 
Via Benzinga
What 12 Analyst Ratings Have To Say About Nevro
Nevro (NYSE:NVRO) has observed the following analyst ratings within the last... 
Via Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Where Nevro Stands With Analysts
Analysts have provided the following ratings for Nevro (NYSE:NV... 
Via Benzinga
A Look Into Nevro's Debt
Over the past three months, shares of Nevro (NYSE:NVRO) increased by 18.38%. Before having a look at the importance of debt, let us look at how much debt Nevro has. Nevro... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
Why Nevro Is Falling So Hard Today
A narrower-than-expected loss was about the only bright spot in the company's second-quarter results. 
Via The Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; SiTime Shares Gain After Strong Q2 Results
Toward the end of trading Thursday, the Dow traded up 0.58% to 34,994.11 while the NASDAQ rose 0.69% to 14,881.97. The S&P also rose, gaining 0.42% to 4,421.35. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nautilus Biotechnology (NASDAQ:NAUT) stock rose 25.23% to $9.38 during Thursday's regular session. Nautilus Biotechnology's stock is trading at a volume of... 
Via Benzinga
Mid-Day Market Update: Dow Surges 200 Points; Itron Shares Tumble Following Downbeat Earnings
Midway through trading Thursday, the Dow traded up 0.58% to 34,992.85 while the NASDAQ rose 0.61% to 14,870.44. The S&P also rose, gaining 0.14% to 4,420.81. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Nevro Stock Tanks After Q2 Earnings Miss, Analysts Move To Sidelines
Nevro Corp (NYSE: NVRO) posted second-quarter revenue of $102.3 million, +81% Y/Y, missing the consensus of $107.7 million. Total U.S. permanent implant procedures... 
Via Benzinga
Topics Earnings
Exposures Financial
Mid-Morning Market Update: Markets Open Higher; Kellogg Tops Q2 Views
Following the market opening Thursday, the Dow traded up 0.49% to 34,961.76 while the NASDAQ rose 0.39% to 14,837.81. The S&P also rose, gaining 0.34% to 4,417.73. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2021
Upgrades Stephens & Co. upgraded the previous rating for Roku Inc (NASDAQ: 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Keybanc boosted the price target for HubSpot, Inc. (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares rose 42.78% to $5.84 during Thursday's pre-market session. The company's market cap stands at $141.7 million.... 
Via Benzinga
Nevro Corp (NVRO) Q2 2021 Earnings Call Transcript
NVRO earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Scopus BioPharma (NASDAQ:SCPS) s... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
h2>Upgrades According to HSBC, the prior rating for NIO Inc (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2021
Upgrades According to Citigroup, the prior rating for ORIC Pharmaceuticals Inc (NASDAQ: 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Keybanc boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $775 to $950. NVIDIA shares rose 0.6% to $824.60 in pre-market trading. Goldman Sachs boosted American... 
Via Benzinga
44 Stocks Moving In Monday's Mid-Day Session
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Barclays raised the price target for Accenture plc (NYSE: 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.